These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18798698)

  • 1. Evolving concepts in liver tissue modeling and implications for in vitro toxicology.
    Guillouzo A; Guguen-Guillouzo C
    Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1279-94. PubMed ID: 18798698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General review on in vitro hepatocyte models and their applications.
    Guguen-Guillouzo C; Guillouzo A
    Methods Mol Biol; 2010; 640():1-40. PubMed ID: 20645044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicogenomics-based prediction of acetaminophen-induced liver injury using human hepatic cell systems.
    Rodrigues RM; Heymans A; De Boe V; Sachinidis A; Chaudhari U; Govaere O; Roskams T; Vanhaecke T; Rogiers V; De Kock J
    Toxicol Lett; 2016 Jan; 240(1):50-9. PubMed ID: 26497421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.
    Godoy P; Hewitt NJ; Albrecht U; Andersen ME; Ansari N; Bhattacharya S; Bode JG; Bolleyn J; Borner C; Böttger J; Braeuning A; Budinsky RA; Burkhardt B; Cameron NR; Camussi G; Cho CS; Choi YJ; Craig Rowlands J; Dahmen U; Damm G; Dirsch O; Donato MT; Dong J; Dooley S; Drasdo D; Eakins R; Ferreira KS; Fonsato V; Fraczek J; Gebhardt R; Gibson A; Glanemann M; Goldring CE; Gómez-Lechón MJ; Groothuis GM; Gustavsson L; Guyot C; Hallifax D; Hammad S; Hayward A; Häussinger D; Hellerbrand C; Hewitt P; Hoehme S; Holzhütter HG; Houston JB; Hrach J; Ito K; Jaeschke H; Keitel V; Kelm JM; Kevin Park B; Kordes C; Kullak-Ublick GA; LeCluyse EL; Lu P; Luebke-Wheeler J; Lutz A; Maltman DJ; Matz-Soja M; McMullen P; Merfort I; Messner S; Meyer C; Mwinyi J; Naisbitt DJ; Nussler AK; Olinga P; Pampaloni F; Pi J; Pluta L; Przyborski SA; Ramachandran A; Rogiers V; Rowe C; Schelcher C; Schmich K; Schwarz M; Singh B; Stelzer EH; Stieger B; Stöber R; Sugiyama Y; Tetta C; Thasler WE; Vanhaecke T; Vinken M; Weiss TS; Widera A; Woods CG; Xu JJ; Yarborough KM; Hengstler JG
    Arch Toxicol; 2013 Aug; 87(8):1315-530. PubMed ID: 23974980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competency of different cell models to predict human hepatotoxic drugs.
    Gómez-Lechón MJ; Tolosa L; Conde I; Donato MT
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1553-68. PubMed ID: 25297626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A liver-derived rat epithelial cell line from biliary origin acquires hepatic functions upon sequential exposure to hepatogenic growth factors and cytokines.
    De Kock J; Snykers S; Branson S; Jagtap S; Gaspar JA; Sachinidis A; Vanhaecke T; Rogiers V
    Curr Med Chem; 2012; 19(26):4523-33. PubMed ID: 22934771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel transcriptomics based in vitro method to compare and predict hepatotoxicity based on mode of action.
    De Abrew KN; Overmann GJ; Adams RL; Tiesman JP; Dunavent J; Shan YK; Carr GJ; Daston GP; Naciff JM
    Toxicology; 2015 Feb; 328():29-39. PubMed ID: 25475144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human hepatocytes as a tool for studying toxicity and drug metabolism.
    Gómez-Lechón MJ; Donato MT; Castell JV; Jover R
    Curr Drug Metab; 2003 Aug; 4(4):292-312. PubMed ID: 12871046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicogenomics directory of chemically exposed human hepatocytes.
    Grinberg M; Stöber RM; Edlund K; Rempel E; Godoy P; Reif R; Widera A; Madjar K; Schmidt-Heck W; Marchan R; Sachinidis A; Spitkovsky D; Hescheler J; Carmo H; Arbo MD; van de Water B; Wink S; Vinken M; Rogiers V; Escher S; Hardy B; Mitic D; Myatt G; Waldmann T; Mardinoglu A; Damm G; Seehofer D; Nüssler A; Weiss TS; Oberemm A; Lampen A; Schaap MM; Luijten M; van Steeg H; Thasler WE; Kleinjans JC; Stierum RH; Leist M; Rahnenführer J; Hengstler JG
    Arch Toxicol; 2014 Dec; 88(12):2261-87. PubMed ID: 25399406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.
    van Wenum M; Treskes P; Adam AAA; van der Mark VA; Jongejan A; Moerland PD; van Gulik TM; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
    Cell Physiol Biochem; 2018; 48(5):2189-2204. PubMed ID: 30110678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies.
    Mueller D; Krämer L; Hoffmann E; Klein S; Noor F
    Toxicol In Vitro; 2014 Feb; 28(1):104-12. PubMed ID: 23850736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell-derived hepatocytes and their use in toxicology.
    Guguen-Guillouzo C; Corlu A; Guillouzo A
    Toxicology; 2010 Mar; 270(1):3-9. PubMed ID: 19815049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes.
    Jetten MJ; Kleinjans JC; Claessen SM; Chesné C; van Delft JH
    Toxicol In Vitro; 2013 Oct; 27(7):2031-40. PubMed ID: 23911569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies.
    Gunness P; Mueller D; Shevchenko V; Heinzle E; Ingelman-Sundberg M; Noor F
    Toxicol Sci; 2013 May; 133(1):67-78. PubMed ID: 23377618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Conserved Toxicogenomic Responses in Chemically Exposed Hepatocytes across Species and Platforms.
    El-Hachem N; Grossmann P; Blanchet-Cohen A; Bateman AR; Bouchard N; Archambault J; Aerts HJ; Haibe-Kains B
    Environ Health Perspect; 2016 Mar; 124(3):313-20. PubMed ID: 26173225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications.
    Lauschke VM; Shafagh RZ; Hendriks DFG; Ingelman-Sundberg M
    Biotechnol J; 2019 Jul; 14(7):e1800347. PubMed ID: 30957976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human.
    Andersson TB; Kanebratt KP; Kenna JG
    Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):909-20. PubMed ID: 22568886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro.
    Nguyen DG; Funk J; Robbins JB; Crogan-Grundy C; Presnell SC; Singer T; Roth AB
    PLoS One; 2016; 11(7):e0158674. PubMed ID: 27387377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of coumarin-induced toxicity between sandwich-cultured primary rat hepatocytes and rats in vivo: a toxicogenomics approach.
    Kienhuis AS; Wortelboer HM; Hoflack JC; Moonen EJ; Kleinjans JC; van Ommen B; van Delft JH; Stierum RH
    Drug Metab Dispos; 2006 Dec; 34(12):2083-90. PubMed ID: 16963487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New perspectives in the use of human hepatocytes in the preclinical drug development process].
    Guillouzo A
    Ann Pharm Fr; 2008; 66(5-6):288-95. PubMed ID: 19061728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.